Teva’s new plant no longer idle
Executive Summary
Teva's new Jerusalem plant passed FDA inspection last month and is now operating, the generic firm announces during an analyst call Feb. 13. The plant was scheduled to be fully operational in early 2006 (1"The Pink Sheet" Aug. 14, 2006, p. 6). CEO Israel Makov says the plant started with a capacity of four billion tablets a year, with a goal to double that by year end...